top of page

#travelwithcolab

this year promises to be another filled with interesting conversations, dynamic dialogues and learning, lots of learning – across the...

ASCO 2020 clinical advances of the year

ASCO has published their annual report on progress against cancer – the report highlights the most important clinical research advances...

if not now, when?

do we want an innovative canada or are we ok with a balanced-book kind of canada? if that isn’t the million dollar question these days....

car-t. one year later

on september 5.2018 health canada gave a notice of compliance [NOC] for tisagenlecleucel [kymriah]. it was the first chimeric antigen...

managing expectations

car t-cell therapy is the next big cancer treatment hitting the canadian cancer treatment landscape— with one recently approved car...

how car-t is an opportunity for canada

the arrival of car t-cell therapy is disrupting the canadian healthcare system, but it has also offered an opportunity for canada to...

biosimilars. the european experience

the cancer collaborative hosted a webinar on June 19 2019 with jatinder harchowal from the NHS whereby he provided insight into the NHS’...

it’s that time of year!

pre-ASCO highlights 2019 it’s that time of year again. the world of oncology is gathering in chicago this weekend for the american...

biosimilars. past talk to action

biosimilars aren’t coming, they’re here. in 2010 health canada published the HC Guidance document: information and submission...

bottom of page